AstraZeneca’s Tagrisso plus chemo recommended for approval in EU
Recommendation based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months
Recommendation based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months
The state-of-the-art facility is equipped with best-in-class equipment and control systems
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Subscribe To Our Newsletter & Stay Updated